#clinicaltrial #clinicaltrials #blockchainbased #blockchain #designing #b2bnews #fcd #firstconnectdigital #firstconnectgroup

Techseriesinsight > Blog > #clinicaltrial #clinicaltrials #blockchainbased #blockchain #designing #b2bnews #fcd #firstconnectdigital #firstconnectgroup

July 18, 2025
Business Wire
Biotechnology, News

BMS Reveals Reblozyl Phase 3 Results

Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 INDEPENDENCE trial evaluating Reblozyl (luspatercept-aamt) with concomitant janus kinase inhibitor (JAKi) therapy in adult patients with myelofibrosis-associated anemia receiving red blood...

June 27, 2024
PRNewswire
Blockchain Technology

LabTrace Completes the First Study Using its Blockchain-Based Data Authentication System, Designed to Ensure Data Integrity in Clinical Trials

LabTrace, a blockchain authentication system for data integrity and ownership certification, today announces the completion of the first experimental medicine study (ref ID: NCT03782753) to utilize its on-chain notarization tool,...